The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel

Assuta Hospital Systems

Status: Completed

Conditions: Streptococcal Infection Group B as Cause of Diseases Classified Elsewhere (Diagnosis)

Study type: Observational

Funder types: Other

Identifiers

NCT04222907

0008-17

Details and patient eligibility

About

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

Full description

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.

Enrollment: 54,759 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

Exclusion criteria

• repeat pregnancies occurring in the same woman during the time period
• multiple pregnancies
• gestational age greater than 42 weeks due to probability of data inaccuracy
• women with missing information

Trial design

54,759 participants in 2 patient groups

Women screened for GBS

Description:

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were screened for GBS during pregnancy

Women not screened for GBS

Description:

All women who were pregnant during 2015-2016 and delivery was between 37-42 weeks who were not screened for GBS during pregnancy